vitamin D deficiency. Vitamin D deficiency
Conditions
Interventions
Intervention 1: first intervention group: 1000 IU/day vitamin D and placebo of 50000 IU/month vitamin D. Intervention 2: second intervention group: 50000 IU/month vitamin D and placebo of 1000 IU/day
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: having light or moderate physical activity willingness to cooperate those whose serum vitamin D were below 30 ng/ml in screening
Exclusion criteria
Exclusion criteria: people who have used calcium and vitamin D supplements in the last 2 months having liver and kidney failure having Steatorrhea having atherosclerosis using medications that affect vitamin D metabolism, such as parathormone, estrogen and calcitonin having sarcoidosis, hyperparathyroidism, renal diseases and histoplasmosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum vitamin D level. Timepoint: at the beginning(before intervention), 61st day after intervention. Method of measurement: Autoanalizer device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Parathyroid hormones. Timepoint: before the intervention , 61st day after intervention. Method of measurement: auto-analyser device.;Serum calcium level. Timepoint: before the intervention , 61st day after intervention. Method of measurement: auto-analyser device.;Serum phosphorus level. Timepoint: before the intervention , 61st day after intervention. Method of measurement: auto-analyser device.;Fibroblast growth factor 23. Timepoint: before the intervention , 61st day after intervention. Method of measurement: ELISA method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoume Akhlaghi
Shiraz University of Medical Sciences
Outcome results
None listed